Bain Capital Life Sciences Investors, LLC
CIK 1703031 · Holdings on Sep 30, 2024 · First reported Nov 14, 2024
Top ten holdings
Q3 2024- NUVL28.71%
- NAMS18.09%
- IRON9.18%
- DNTH8.58%
- SVRA6.43%
- PHVS6.36%
- ANNX5.20%
- SLDB2.93%
- TNGX2.17%
- KYTX1.71%
Share classes counted separately89.36%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- NUVLWeight increased · +6.25 pp22.46% → 28.71%Shares 0 (0.00%)
- NAMSWeight decreased · -4.00 pp22.09% → 18.09%Shares 0 (0.00%)
- KYTXWeight decreased · -1.06 pp2.77% → 1.71%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 24
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NUVLNUVALENT INC-A View history and evidence | $275.93M | 28.71% | 2.70M shares | 22.46% → 28.71%+6.25 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | NAMSNEWAMSTERDAM PHARMA CO NVORDINARY SHARES View history and evidence | $173.87M | 18.09% | 10.47M shares | 22.09% → 18.09%-4.00 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | IRONDISC MEDICINE INC View history and evidence | $88.24M | 9.18% | 1.80M shares | 8.89% → 9.18%+0.29 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | DNTHDIANTHUS THERAPEUTICS INC View history and evidence | $82.51M | 8.58% | 3.01M shares | 8.56% → 8.58%+0.02 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | SVRASAVARA INC View history and evidence | $61.76M | 6.43% | 14.57M shares | 6.44% → 6.43%-0.01 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | PHVSPHARVARIS NV View history and evidence | $61.18M | 6.36% | 3.30M shares | 6.82% → 6.36%-0.46 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | ANNXANNEXON INC View history and evidence | $50.02M | 5.20% | 8.45M shares | 4.55% → 5.20%+0.65 pp +540 (+0.01%) | Added | ↗▾ |
| 08 | SLDBSOLID BIOSCIENCES INCCOM NEW View history and evidence | $28.12M | 2.93% | 4.03M shares | 2.51% → 2.93%+0.42 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | TNGXTANGO THERAPEUTICS INC View history and evidence | $20.88M | 2.17% | 2.71M shares | 2.72% → 2.17%-0.55 pp -180.66K (-6.25%) | Reduced | ↗▾ |
| 10 | KYTXKYVERNA THERAPEUTICS INC View history and evidence | $16.47M | 1.71% | 3.37M shares | 2.77% → 1.71%-1.06 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 2
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| ARQT ARCUTIS BIOTHERAPEUTICS INC | Non-derivative | -1,030,703 | -$9.59M | SEC filing ↗ | SEC filing ↗ |
| ACRS ACLARIS THERAPEUTICS INC | Non-derivative | -1,000,000 | -$1.10M | SEC filing ↗ | SEC filing ↗ |
2 / 2 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1703031 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2024-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 961175669
}Take these holdings further.
This page includes 24 of 24 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 24 of 24 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1703031","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1703031","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.